Presentation TCT 2018 BIONYX: Summary and Clinical Implications Presenter: Sripal Bangalore, Lawrence A. Garcia, Clemens von Birgelen September 22, 2018
Presentation TCT 2018 The Overview of Current Evidence of RDN: The Result of RADIANCE-HTN SOLO Trial and SPYRAL HTN-on MED Trial Presenter: Kenneth J. Cavanaugh Jr, Takafumi Ueno, Justin E. Davies September 22, 2018
Presentation TCT 2018 Patient-Centered Engagement in Trials: Case Example - ADAPTABLE Presenter: John C Laschinger, J. Dawn Abbott, Lori M Ashby, Robert A. Byrne, David A. Cox, Mona Fiuzat, Christopher O'Connor, John A. Spertus, Susan Strong September 22, 2018
Presentation TCT 2018 FDAs Patient Engagement Initiatives: How FDA Can Incorporate Patient Centered and Patient Reported Outcomes in Regulatory Decision-Making Presenter: John C Laschinger September 22, 2018
Presentation TCT 2018 The Current Target Population for LAAC Closure Based on the Results of Clinical Trials in Europe Presenter: Marek Grygier September 22, 2018
Presentation TCT 2018 The Overview of Clinical Trials and Current Target Population for LAAC Closure Presenter: Shephal Doshi September 22, 2018
Presentation TCT 2018 How the Best-CLI Trial Will Change Clinical Practice Presenter: Ehrin J. Armstrong, Sahil A. Parikh, Matthew T. Menard September 22, 2018
Presentation TCT 2018 Clinical Trials for Short DAPT: FDA Perspective Presenter: Christopher J Popma September 22, 2018
Presentation TCT 2018 Status Update of the TAVR UNLOAD Trial Moderate AS Patients with Reduced Ejection Fraction and Heart Failure Presenter: Allan Schwartz, Stephan Windecker, Joost Daemen September 22, 2018
Presentation TCT 2018 Rationale for Treating SASS and Update of the EARLY-TAVR Trial Presenter: Allan Schwartz September 22, 2018
Presentation TCT 2018 The Case for TAVR in Low-Risk Patients: Rationale, Current Data, Clinical Trends, and Updates from the Ongoing Clinical Trials Presenter: Allan Schwartz, Stephan Windecker, Jeffrey J. Popma September 22, 2018
Presentation TCT 2018 Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials Presenter: Alexandra J. Lansky, Axel Linke, Tamim Nazif September 22, 2018
Presentation TCT 2018 IABP in Cardiogenic Shock: Reconciling Clinical Trial Results and Guidelines With Real-World Experience (With Practical-use Recommendations) Presenter: Cindy L. Grines, E. Magnus Ohman, Richard Smalling September 22, 2018
Presentation TCT 2018 Most Important Clinical Trials in Vascular Medicine and Intervention in the Past 10 Years Presenter: Jay S. Giri, Sahil A. Parikh September 22, 2018
Presentation TCT 2018 TCT-120: Long-term Outcomes in Women and Men Following Percutaneous Coronary Intervention: An Individual Patient Data Pooled Analysis from 21 Randomized Trials Presenter: Michael A. Kutcher, Tullio Palmerini, Ioanna Kosmidou September 21, 2018
Presentation TCT 2018 TCT-112: Patient-Oriented Clinical Outcomes and Net Adverse Cardiovascular Event in the Global Leaders Trial Presenter: George D. Dangas, Germano Di Sciascio, Patrick W. Serruys September 21, 2018
Presentation TCT 2018 TCT-119: Impact of Clinical Syndrome on Outcomes After PCI: Analysis From a Large Pooled Randomized Trial Dataset Presenter: Michael A. Kutcher, Tullio Palmerini, Masaru Ishida September 21, 2018
Presentation TCT 2018 TCT-118: The Impact of Bifurcation Stenting Techniques on the Clinical Events: the Stratified Analysis of 2,510 Bifurcated Lesions According to MADS Classification in the Global LEADERS Trial Presenter: Michael A. Kutcher, Tullio Palmerini, Norihiro Kogame September 21, 2018